These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 37611660)

  • 1. The Impact of Blood Glucose Test Strips Reimbursement Limits on Utilization, Costs, and Health-care Utilization in British Columbia.
    Itiola AJ; Cheng L; Zhang W; Gomes T; Shah BR; Law MR
    Can J Diabetes; 2024 Feb; 48(1):10-17.e5. PubMed ID: 37611660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-Monitoring of Blood Glucose: Impact of Quantity Limits in Public Drug Formularies on Provincial Costs Across Canada.
    Knowles SR; Lee K; Paterson JM; Shah BR; Mamdani MM; Juurlink DN; Gomes T
    Can J Diabetes; 2017 Apr; 41(2):138-142. PubMed ID: 27989494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of policies to reduce blood glucose test strip utilization and costs in Canada.
    Gomes T; Martins D; Cheng L; Kratzer J; Juurlink DN; Shah BR; Mamdani MM; Paterson JM; Law MR
    Can J Public Health; 2015 Apr; 106(4):e210-6. PubMed ID: 26285192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Self-Monitoring of Blood Glucose Levels: Evaluating the Impact of a Policy of Quantity Limits on Test-Strip Use and Costs.
    Gomes T; Martins D; Tadrous M; Paterson JM; Shah BR; Juurlink DN; Singh S; Mamdani MM
    Can J Diabetes; 2016 Oct; 40(5):431-435. PubMed ID: 27212047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunity Cost and Policy: A Utilization Review of Self-monitoring of Blood Glucose in Manitoba, Canada.
    Serwylo O; Friesen K; Falk J; Bugden S
    Clin Ther; 2016 Apr; 38(4):929-35. PubMed ID: 26947797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns, Policy and Appropriateness: A 12-Year Utilization Review of Blood Glucose Test Strip Use in Insulin Users.
    Falk J; Friesen KJ; Okunnu A; Bugden S
    Can J Diabetes; 2017 Aug; 41(4):385-391. PubMed ID: 28410881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in Blood Glucose Test Strip Utilization: A Population-Wide Analysis in Saskatchewan, Canada.
    Kosar L; Alsabbagh W; Lu X; Lix LM; Shevchuk Y; Teare GF; Champagne A; Blackburn DF
    Can J Diabetes; 2018 Feb; 42(1):5-10. PubMed ID: 28499790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rational use of blood glucose test strips for self-monitoring in patients with diabetes mellitus: Economic impact in the Portuguese healthcare system.
    Risso T; Furtado C
    Diabetes Res Clin Pract; 2017 Dec; 134():161-167. PubMed ID: 28951334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of a Blood Glucose Test Strip Quantity-Limit Policy With Patient Outcomes: A Population-Based Study.
    Gomes T; Martins D; Tadrous M; Paterson JM; Shah BR; Tu JV; Juurlink DN; Chu A; Mamdani MM
    JAMA Intern Med; 2017 Jan; 177(1):61-66. PubMed ID: 27820619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitus.
    Tavares R; Duclos M; Brabant MJ; Checchin D; Bosnic N; Turvey K; Terres JA
    Acta Diabetol; 2016 Jun; 53(3):483-92. PubMed ID: 26972690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
    Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
    Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes.
    Yeaw J; Lee WC; Aagren M; Christensen T
    J Manag Care Pharm; 2012; 18(1):21-32. PubMed ID: 22235952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between type of drug therapy and blood glucose self-monitoring test strips claimed by beneficiaries of the Seniors' Pharmacare Program in Nova Scotia, Canada.
    Sanyal C; Graham SD; Cooke C; Sketris I; Frail DM; Flowerdew G
    BMC Health Serv Res; 2008 May; 8():111. PubMed ID: 18501012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flash Glucose Monitoring System for People with Type 1 or Type 2 Diabetes: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2019; 19(8):1-108. PubMed ID: 31942227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Clinical Practice Guidelines on Blood Glucose Test Strip Prescription Rates in Manitoba and Saskatchewan (Canada): An Interrupted Time-Series Analysis.
    Nichols J; Mamdani M; Gomes T; Shah BR; Casey CG; Yu CH
    Can J Diabetes; 2021 Aug; 45(6):557-565.e2. PubMed ID: 33558147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Net health plan savings from reference pricing for angiotensin-converting enzyme inhibitors in elderly British Columbia residents.
    Schneeweiss S; Dormuth C; Grootendorst P; Soumerai SB; Maclure M
    Med Care; 2004 Jul; 42(7):653-60. PubMed ID: 15213490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and economic consequences of a reimbursement restriction of nebulised respiratory therapy in adults: direct comparison of randomised and observational evaluations.
    Schneeweiss S; Maclure M; Carleton B; Glynn RJ; Avorn J
    BMJ; 2004 Mar; 328(7439):560. PubMed ID: 14982865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Impact of reference pricing on prescribing patterns, costs, and health services utilization of proton pump inhibitors: A quasi-experimental study in British Columbia, Canada.
    Au SW; Law MR; Cheng L; McGrail K; Harrison M
    Health Policy; 2024 Jun; 144():105061. PubMed ID: 38676977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The estimated costs and savings of medical nutrition therapy: the Medicare population.
    Sheils JF; Rubin R; Stapleton DC
    J Am Diet Assoc; 1999 Apr; 99(4):428-35. PubMed ID: 10207394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.